Ethnic minority female participants do not have the same protection from CHD as Europeans, and greater cardiometabolic burden may drive this elevated CHD risk and loss of female protection.
Abstract
Background and aims: Sex differences in ethnic minority risk of coronary heart disease (CHD) are often overlooked. Here we aim to explore sex-by-ethnicity differences in CHD outcomes and the contribution of risk factors. Methods: Incident CHD events were identified for Europeans, and South Asian and African/African Caribbean first generation migrants in the UK-based Southall and Brent Revisited (SABRE) cohort. Cardiovascular risk factors were assessed at baseline (1988-91). Cox proportional hazards models quantified group differences in CHD incidence and risk factor contribution. Population attributable fractions (PAFs) described risk factor contribution to group differences. Results: Among 4,754 participants followed for 40.8 years, 1,710 CHD first events occurred. Cumulative incidence of CHD was highest in South Asian males (65% by age 90) and females (55%), compared with 52% in European males and 24-31% in other groups. Sex differences in CHD incidence were pronounced in Europeans (female versus male HR=0.45, 95% CI [0.37,0.55]) but attenuated in South Asians (0.68 [0.56,0.82]) and African/African Caribbeans (0.79 [0.57,1.10]). CHD risk was higher in South Asian compared to European men (1.80 [1.63,1.99]). This ethnic difference was greater in females (2.44 [1.88,3.17]). PAFs for diabetes (PAF=18.0%, 95% CI [6.2,29.8]), hypercholesterolemia (44.2% [20.4,68.1]), and hypertriglyceridemia (22.4% [7.9,37.0]) made a greater contribution to the risk of CHD in South Asian females compared to all other groups. Conclusions: Ethnic minority female participants do not have the same protection from CHD as Europeans. Greater cardiometabolic burden may drive this elevated CHD risk and loss of female protection.
Background Despite growing evidence of sex-specific differences in cardiovascular (CV) disease, sex-specific prevention strategies are lacking. Objectives This study aims to examine CV risk factors according to age and sex in a German working population. Methods In collaboration with ias PREVENT, a provider of medical...
J. Lueg, Daniel Schulze, Henrike Radefeld et al.· JACC: Advances· 0 citations
INTRODUCTION
Sex differences in cardiovascular disease (CVD) risk are examined through biological and clinical factors, with less attention to early-life social exposures. This study examined associations of childhood parental son preference with CVD risk, sex differences, and mediation by modifiable risk factors.
ME...
Jingfei Lyu, Meng Xiao, Biao-Chuan He· American Journal of Preventi...· 0 citations
Age 65 years or older, smoking, and male sex increased the risk of CVD mortality in this Iranian cohort, while physical activity and higher educational attainment were associated with a reduced risk of CVD mortality.
M. Sarebanhassanabadi, Samira Qaderi, Mahdi Karimi et al.· ARYA Atherosclerosis· 0 citations
Sex-specific differences in the effects and contributions of risk factor profiles highlight the need for tailored MACE prevention strategies and polygenic risk provided modest additional discrimination in males, supporting further evaluation of precise cardiovascular risk assessment.
Yu-Hui Yang, Xi Chen, Yu-Hao Hu et al.· Frontiers in Cardiovascular...· 0 citations
BACKGROUND
Asian adults in the U.S. face increased burdens of cardiovascular risk factors and cardiovascular disease (CVD). However, trends in cardiovascular health among Asian subgroups remain understudied.
OBJECTIVES
The purpose of this study was to examine 15-year trends in CVD risk factors and CVD among Chinese,...
Xiaoyue Liu, E. Ea, Gail Melkus et al.· Nursing Research· 0 citations
BACKGROUND AND AIMS
This nationwide registry study examined sex-specific differences in acute coronary syndrome management and all-cause mortality in Hungary between 2014 and 2024.
METHODS
Data from 184,616 patients in the Hungarian National Myocardial Infarction Register were analyzed. Median follow-up was 3.1 years...
Csaba Sári, Orsolya Bárdos-Csenteri, Péter Takács et al.· Atherosclerosis· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.